Source: Virtual Congress 2021 – Therapy of lung cancer



Rating:

Share or cite this content

Citations should be made in the following way:
J. Groves (Letchworth(Hertfordshire), United Kingdom), R. Yeo ( Hertfordshire), United Kingdom), Y. Tsang ( Hertfordshire), United Kingdom), N. Shah ( Hertfordshire), United Kingdom), T. Win (Stevenage (Hertfordshire), United Kingdom). Clinical outcomes of stereotactic ablative body radiotherapy (SABR) in medically inoperable early stage lung cancer patients. 2293

Member's Comments

No comment yet.

Related content which might interest you: SABRTooth: a randomised controlled feasibility study of stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I nonsmall cell lung cancer considered to be at higher risk of complications from surgical resection Source: Eur Respir J, 56 (5) 2000118; 10.1183/13993003.00118-2020 Year: 2020 Surgical salvage following stereotactic body radiotherapy for early-stage NSCLC Source: Eur Respir J 2012; 39: 1039-1042 Year: 2012 Impact of neoadjuvant therapies on surgical indications and early postoperative outcome Source: Annual Congress 2005 - Multidisciplinary treatment of non-metastatic non-small cell lung cancer: contemporary concepts Year: 2005 Radical radiotherapy alone in medically inoperable early stage I non small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 755s Year: 2006 Surgical treatment of lung cancer after polyhemothetapy/radiotherapy down-staging in patients initially assessed as inoperable Source: Eur Respir J 2006; 28: Suppl. 50, 718s Year: 2006 Salvage lung resection for local recurrence after stereotactic body radiotherapy for primary and metastatic lung cancers Source: Annual Congress 2011 - General thoracic surgery I Year: 2011 Long-term follow-up comparing postoperative chemotherapy or radiotherapy and surgery with surgery alone in resectable nonsmall cell lung cancer (NSCLC) Source: Eur Respir J 2001; 18: Suppl. 33, 131s Year: 2001 Treatment of potentially resectable locoregional (stage III) non-small cell lung cancer Source: Annual Congress 2005 - PG2 - Lung cancer: non-small cell lung cancer treatment Year: 2005 Will stereotactic body radiotherapy prolong survival in patients with stage IV NSCLC? Source: European Multidisciplinary Conference in Thoracic Oncology 2009 Year: 2009 Complete endosonographic nodal staging of lung cancer in patients eligible for stereotactic ablative radiotherapy (STAGE study NCT02997449) Source: International Congress 2017 – Interventional pulmonology highlights 2017 Year: 2017 ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy) Source: Eur Respir J 2009; 34: 17-41 Year: 2009 Hypofractionated radiotherapy for stage I lung carcinomas: moderate hypofractionation optimizes outcome Source: International Congress 2018 – Lung cancer: personalised medicine Year: 2018 Radical radiotherapy in medically inoperable early stage non-small cell lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 318s Year: 2001 Adjuvant chemotherapy and prophylactic cranial irradiation in the combined treatment for the operable patients with small cell lung cancer I-III stage Source: Eur Respir J 2005; 26: Suppl. 49, 75s Year: 2005 Modern radiotherapy as a curative treatment modality for stage III NSCLC Source: International Congress 2019 – Locally advanced non-small cell lung cancer in 2019: novel diagnostic and therapeutic strategies to tackle complex stage III disease Year: 2019 Treatment of unresectable locoregional (stage III) non-small cell lung cancer Source: Annual Congress 2005 - PG2 - Lung cancer: non-small cell lung cancer treatment Year: 2005 Survival and postoperative complication after neoadjuvant therapy in resectable stage IIIA-N2 non-small cell lung cancer: a balancing exercise Source: Eur Respir J 2003; 22: Suppl. 45, 31s Year: 2003 Early complications after lung resections at patients treated for lung cancer with and without neoadjuvant hemiotheraphy Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer Year: 2011 Locally advanced disease – indications and results of extended resections Source: Annual Congress 2005 - Borderline indications for surgical treatment of non-small cell lung cancer Year: 2005 Indcution chemotherapy and radiotherapy vs. induction and simultaneous radiochemotherapy in inoperable stage III NSCLC. Update on BROCAT study CTRT 99/97 Source: Eur Respir J 2006; 28: Suppl. 50, 833s Year: 2006